| | | | | |
UP Wheels Up Experience Inc. | $7,1900 | -0,14% | $261,07M | $48,98K | |
NUS NuSkin Enterprises, Inc. | $5,2482 | -2,27% | $260,71M | $672,10K | |
AIRO AIRO Group Holdings, Inc. Common Stock | $8,3900 | +1,21% | $260,68M | $376,64K | |
ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | $3,5700 | -2,46% | $260,54M | $507,39K | |
| $2,9800 | +4,20% | $259,95M | $841,32K | |
DEFT Defi Technologies, Inc. | $0,56240 | +1,70% | $259,84M | $3,21M | |
FACT FACT II Acquisition Corp. Class A Ordinary Shares | $10,6500 | -0,28% | $259,75M | $37,22K | |
| $3,2100 | +0,94% | $259,24M | $343,27K | |
| $18,7300 | -1,32% | $258,92M | $103,66K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,4000 | +0,59% | $258,44M | $349,03K | |
TWFG TWFG, Inc. Common Stock | $19,8850 | +0,08% | $258,25M | $505,87K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | $5,4700 | +0,18% | $257,83M | $195,23K | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | $10,6400 | -0,19% | $257,70M | $13,01K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | $10,6100 | +0,00% | $257,57M | $18,45K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | $10,6300 | -0,09% | $257,32M | $2,09K | |
